ReviewWorld journal of gastroenterology2025
Foundation models: Insights and implications for gastrointestinal cancer.
Review in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research progress and challenges of multimodal deep learning models for prognosis of gastric cancer.Discover oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal (GI) cancers represent a major global health concern due to their high incidence and mortality rates. Foundation models (FMs), also referred to as large models, represent a novel class of artificial intelligence technologies that have demonstrated considerable potential in addressing these challenges. These models encompass large language models (LLMs), vision FMs (VFMs), and multimodal LLMs (MLLMs), all of which utilize transformer architectures and self-supervised pre-training on extensive unlabeled datasets to achieve robust cross-domain generalization. This review delineates the principal applications of these models: LLMs facilitate the structuring of clinical narratives, extraction of insights from medical records, and enhancement of physician-patient communication; VFMs are employed in the analysis of endoscopic, radiological, and pathological images for lesion detection and staging; MLLMs integrate heterogeneous data modalities, including imaging, textual information, and genomic data, to support diagnostic processes, treatment prediction, and prognostic evaluation. Despite these promising developments, several challenges remain, such as the need for data standardization, limited diversity within training datasets, substantial computational resource requirements, and ethical-legal concerns. In conclusion, FMs exhibit significant potential to advance research and clinical management of GI cancers. Future research efforts should prioritize the refinement of these models, promote international collaborations, and adopt interdisciplinary approaches. Such a comprehensive strategy is essential to fully harness the capabilities of FMs, driving substantial progress in the fight against GI malignancies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.